The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target? (Q38033647)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882204%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882204%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

10 February 2020

main subject

1 reference

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882204%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Andrew Lansdown

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882204%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

1 reference

1 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882204%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

published in

Clinical Endocrinology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882204%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882204%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882204%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

791-801

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882204%20AND%20SRC:MED&resulttype=core&format=json

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus

10 February 2020

cites work

1 reference

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

21 January 2018

1 reference

Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study.

21 January 2018

1 reference

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

21 January 2018

1 reference

Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.

21 January 2018

1 reference

Polycystic ovary syndrome is associated with endothelial dysfunction

21 January 2018

1 reference

Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice

21 January 2018

1 reference

Pulse and respiratory grouping of sympathetic impulses in human muscle-nerves

21 January 2018

1 reference

Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover

21 January 2018

1 reference

How to assess sympathetic activity in humans

21 January 2018

1 reference

Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives

21 January 2018

1 reference

A deletion in the alpha2B-adrenergic receptor gene and autonomic nervous function in central obesity

21 January 2018

1 reference

Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome.

21 January 2018

1 reference

Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension

21 January 2018

1 reference

Obesity and adipokines: effects on sympathetic overactivity

21 January 2018

1 reference

Suppression of sympathetic nervous system during fasting.

21 January 2018

1 reference

Brown fat and obesity: the next big thing?

21 January 2018

1 reference

CRTC3 links catecholamine signalling to energy balance

21 January 2018

1 reference

Leptin signaling in the nucleus tractus solitarii increases sympathetic nerve activity to the kidney

21 January 2018

1 reference

Distributed neural control of energy balance: contributions from hindbrain and hypothalamus

21 January 2018

1 reference

Selective resistance to central neural administration of leptin in agouti obese mice

21 January 2018

1 reference

Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin

21 January 2018

1 reference

Insulin acts in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in rats.

21 January 2018

1 reference

Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity

21 January 2018

1 reference

Arcuate nucleus - a gateway for insulin's action on sympathetic activity.

21 January 2018

1 reference

Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans

21 January 2018

1 reference

Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humans

21 January 2018

1 reference

Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans

21 January 2018

1 reference

Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation

21 January 2018

1 reference

Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study

21 January 2018

1 reference

Reflex sympathetic activation induces acute insulin resistance in the human forearm.

21 January 2018

1 reference

Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance

21 January 2018

1 reference

The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome

21 January 2018

1 reference

Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome

21 January 2018

1 reference

Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity

21 January 2018

1 reference

Altered cardiovascular variability in obstructive sleep apnea.

21 January 2018

1 reference

Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications

21 January 2018

1 reference

Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity

21 January 2018

1 reference

Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation

21 January 2018

1 reference

Effects of electro-acupuncture on nerve growth factor and ovarian morphology in rats with experimentally induced polycystic ovaries.

21 January 2018

1 reference

Effect of electro-acupuncture on ovarian expression of alpha (1)- and beta (2)-adrenoceptors, and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries

21 January 2018

1 reference

Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans

21 January 2018

1 reference

Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries

21 January 2018

1 reference

Evidence for altered catecholamine metabolism in polycystic ovary syndrome

21 January 2018

1 reference

Peripheral catecholamine alterations in adolescents with polycystic ovary syndrome

21 January 2018

1 reference

Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?

21 January 2018

1 reference

The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components.

21 January 2018

1 reference

Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects

21 January 2018

1 reference

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review

21 January 2018

1 reference

The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men.

21 January 2018

1 reference

Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity

21 January 2018

1 reference

Effect of pioglitazone on muscle sympathetic nerve activity in type 2 diabetes mellitus with α-glucosidase inhibitor

21 January 2018

1 reference

Insulin resistance and sympathetic overactivity in women

21 January 2018

1 reference

Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome.

21 January 2018

1 reference

Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial

21 January 2018

1 reference

Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome

21 January 2018

1 reference

Renal sympathetic-nerve ablation for uncontrolled hypertension

21 January 2018

1 reference

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

21 January 2018

1 reference

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study

21 January 2018

1 reference

Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial

21 January 2018

1 reference